科研动态PubMed 摘要

经黏膜给予氯胺酮治疗犬骨关节炎慢性疼痛的局限性。

PubMed 白名单日捞 · 2026-10-29

完整摘要 · 中文译文

引言:本前瞻性、开放标签临床试验旨在评估低剂量氯胺酮(0.5 mg/kg)经口腔经黏膜途径每8小时给药,对客户 owned 犬患有难治性慢性骨关节炎疼痛的疗效。 方法:客观步态分析是与疼痛相关的骨科功能的主要结局指标。采用液相色谱-串联质谱法测定口腔经黏膜氯胺酮(TMK)明胶锭剂给药后30分钟和60分钟时血浆氯胺酮和去甲氯胺酮浓度。 结果:由于所提供的制剂难以给药(给药成功率=54%;n=9名受试者中181/334剂次),入组提前终止。所得样本量太小,无法按计划对客观结局数据进行统计分析以确定治疗效果。给药后30分钟时,氯胺酮和去甲氯胺酮的平均血浆浓度(n=8名患者)分别为4.5 ng/mL(+/- 3.0)和47 ng/mL(+/- 38.3);给药后60分钟时分别为1.7 ng/mL(+/- 1.2)和65.7 ng/mL(+/- 46.7)。 讨论:这些数值提示TMK被吸收并随后代谢为去甲氯胺酮。然而,较低给药成功率表明,口腔经黏膜明胶锭剂在临床环境中对于低剂量氯胺酮是一种不实用的给药方法。建议在TMK可临床使用之前,评估替代性TMK制剂,并以适当样本量进一步研究其疗效、药代动力学和药效动力学。

完整摘要 · 英文原文

INTRODUCTION: This prospective, open-label clinical trial aimed to evaluate the efficacy of low-dose keta-mine (0.5 mg/kg) administered by oral transmucosal route every 8 h in client-owned dogs with refractory, chronic osteoarthritis pain. METHODS: Objective gait analysis was the primary outcome measure for orthopedic function relating to pain. Liquid chromatography-tandem mass spectrometry was used to quantify plasma ketamine and norketamine concentrations 30 and 60 min after administration of an oral transmucosal ketamine (TMK) gelatin lozenge. RESULTS: Enrollment was discontinued early due to difficulty of administering TMK in the formulation provided (administration success = 54%; 181/334 doses in n = 9 participants). The result-ing sample size was too small for the intended statistical analysis of objective outcome da-ta to determine treatment efficacy. Mean plasma concentrations of ketamine and norketa-mine (n = 8 patients) were 4.5 ng/mL (+/- 3.0) and 47 ng/mL (+/- 38.3) at 30 min, and 1.7 ng/mL (+/- 1.2) and 65.7 ng/mL (+/- 46.7) at 60 min post administration. DISCUSSION: These values suggest that TMK is absorbed and subsequently metabolized into norketa-mine. However, the low success rate of administration demonstrated that an oral transmu-cosal gelatin lozenge is an impractical delivery method for low-dose ketamine in a clinical setting. Evaluation of alternative TMK formulations and further research with an appropriate sample size is recommended to evaluate efficacy, pharmacokinetics, and pharmacody-namics before TMK can be used clinically.

English
Limitations of transmucosal ketamine administration for chronic pain in dogs with osteoarthritis.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界